And the diminished KRT18 expression was reported to improve the susceptibility of cytokine-induced death of cervical cancer cells (Sullivan et al., 2010) and inhibit cell migration and enhance paclitaxel sensitivity in lung cancer cells (Zhang et al., 2016). Here, KRT18 is linked to lung cancer.